| scholarly article | Q13442814 |
| P50 | author | John Coffin | Q6226532 |
| Bruce D. Walker | Q23770361 | ||
| Gordon J. Freeman | Q27088375 | ||
| Sylvie Le Gall | Q37376422 | ||
| Florencia Pereyra | Q72530851 | ||
| Eric S Rosenberg | Q89548046 | ||
| Alicja Piechocka-Trocha | Q89549631 | ||
| John Zaunders | Q95422081 | ||
| Anthony Kelleher | Q96053206 | ||
| Kristin L Moss | Q114434956 | ||
| Almas Rathod | Q114434963 | ||
| Toshiyuki Miura | Q114434971 | ||
| Mark A. Brockman | Q30389078 | ||
| P2093 | author name string | Daniel E Kaufmann | |
| Sarah Palmer | |||
| Baogong Zhu | |||
| Daniel G Kavanagh | |||
| Brett Baker | |||
| Michael T Waring | |||
| Ryan Ahern | |||
| Elizabeth W Mackey | |||
| P2860 | cites work | Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production | Q24292957 |
| CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms | Q24534904 | ||
| Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma | Q24679736 | ||
| Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides | Q37422520 | ||
| Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection. | Q37567936 | ||
| Human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cells that proliferate in vitro detected in samples from most viremic subjects and inversely associated with plasma HIV-1 levels | Q37596842 | ||
| Murine malaria is exacerbated by CTLA-4 blockade | Q39098212 | ||
| Immunotherapy with OX40L-Fc or anti-CTLA-4 enhances local tissue responses and killing of Leishmania donovani. | Q39634065 | ||
| Lack of intrinsic CTLA-4 expression has minimal effect on regulation of antiviral T-cell immunity. | Q40721856 | ||
| Progress in defining CD4 helper cell responses in chronic viral infections | Q42109893 | ||
| Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma | Q42821039 | ||
| CTLA-4 regulates the murine immune response to Trypanosoma cruzi infection. | Q44005882 | ||
| Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy | Q45721932 | ||
| Effects of sustained HIV-1 plasma viremia on HIV-1 Gag-specific CD4+ T cell maturation and function. | Q51024682 | ||
| Induction of CTLA-4-mediated anergy contributes to persistent colonization in the murine model of gastric Helicobacter pylori infection | Q56902208 | ||
| TGF-beta mediates CTLA-4 suppression of cellular immunity in murine kalaazar | Q56906232 | ||
| Foxp3 programs the development and function of CD4+CD25+ regulatory T cells | Q27860714 | ||
| TNF/TNFR family members in costimulation of T cell responses | Q28240053 | ||
| The B7 family revisited | Q28240070 | ||
| Enhancement of antitumor immunity by CTLA-4 blockade | Q28275730 | ||
| Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4 | Q28284177 | ||
| Restoring function in exhausted CD8 T cells during chronic viral infection | Q28289222 | ||
| CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells | Q29618394 | ||
| PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression | Q29618956 | ||
| Fully differentiated HIV-1 specific CD8+ T effector cells are more frequently detectable in controlled than in progressive HIV-1 infection | Q30830619 | ||
| Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection | Q33869806 | ||
| CTLA-4 upregulation during HIV infection: association with anergy and possible target for therapeutic intervention | Q34521402 | ||
| Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction | Q34570127 | ||
| PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection | Q34570624 | ||
| Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection | Q34571341 | ||
| CTLA-4: new insights into its biological function and use in tumor immunotherapy | Q34711491 | ||
| Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients | Q34959906 | ||
| Suppression of HIV-specific T cell activity by lymph node CD25+ regulatory T cells from HIV-infected individuals | Q35652583 | ||
| Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity | Q35762422 | ||
| Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+ T cells are a consequence of antigen load | Q35784804 | ||
| CTLA-4 blockade decreases TGF-beta, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques | Q35848881 | ||
| HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. | Q35848896 | ||
| Mechanisms of suppression by suppressor T cells | Q36078047 | ||
| Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells | Q36228688 | ||
| CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells | Q36366857 | ||
| Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses | Q36376333 | ||
| CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status | Q36399748 | ||
| A molecular perspective of CTLA-4 function | Q36427322 | ||
| Diminished Proliferation of Human Immunodeficiency Virus-Specific CD4+T Cells Is Associated with Diminished Interleukin-2 (IL-2) Production and Is Recovered by Exogenous IL-2 | Q36474240 | ||
| New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma | Q36891848 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1246-1254 | |
| P577 | publication date | 2007-09-30 | |
| P1433 | published in | Nature Immunology | Q1071725 |
| P1476 | title | Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction | |
| P478 | volume | 8 |
| Q54217761 | A High Frequency of HIV-Specific Circulating Follicular Helper T Cells Is Associated with Preserved Memory B Cell Responses in HIV Controllers. |
| Q36931169 | A comparison of viral loads between HIV-1-infected elite suppressors and individuals who receive suppressive highly active antiretroviral therapy |
| Q33815728 | A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers |
| Q35323147 | A lower viral set point but little immunological impact after early treatment during primary HIV infection |
| Q37458908 | A parameter for IL-10 and TGF-ß mediated regulation of HIV-1 specific T cell activation provides novel information and relates to progression markers |
| Q42055809 | A role for the transcriptional repressor Blimp-1 in CD8(+) T cell exhaustion during chronic viral infection. |
| Q28109688 | Acute Malaria Induces PD1+CTLA4+ Effector T Cells with Cell-Extrinsic Suppressor Function |
| Q33967995 | Alloantigen expression on non-hematopoietic cells reduces graft-versus-leukemia effects in mice. |
| Q91904936 | Altered differentiation is central to HIV-specific CD4+ T cell dysfunction in progressive disease |
| Q39585950 | Amplifying and quantifying HIV-1 RNA in HIV infected individuals with viral loads below the limit of detection by standard clinical assays |
| Q37208517 | An engineered lipocalin specific for CTLA-4 reveals a combining site with structural and conformational features similar to antibodies. |
| Q55450663 | An open-label, multiple ascending dose study of the anti-CTLA-4 antibody ipilimumab in viremic HIV patients. |
| Q34267776 | Animal models for viral infection and cell exhaustion |
| Q35641516 | Antigen-specific CD4 T-cell help rescues exhausted CD8 T cells during chronic viral infection. |
| Q38090495 | Apoptosis - an Ubiquitous T cell Immunomodulator |
| Q45097081 | Are senescence and exhaustion intertwined or unrelated processes that compromise immunity? |
| Q26823033 | Association of HLA-alleles with the immune regulation of chronic viral infections |
| Q35080089 | Attenuation of HIV-associated human B cell exhaustion by siRNA downregulation of inhibitory receptors |
| Q37705556 | B and T lymphocyte attenuator down-regulation by HIV-1 depends on type I interferon and contributes to T-cell hyperactivation |
| Q35073276 | B cell responses to HIV antigen are a potent correlate of viremia in HIV-1 infection and improve with PD-1 blockade |
| Q34605780 | B cells in HIV infection and disease |
| Q36171833 | B-lymphocyte dysfunction in chronic HIV-1 infection does not prevent cross-clade neutralization breadth. |
| Q48013543 | Belatacept Conversion in an HIV-Positive Kidney Transplant Recipient With Prolonged Delayed Graft Function |
| Q47708589 | Belatacept conversion in an HIV-positive kidney transplant recipient following anti-thymocyte globulin induction. |
| Q48113493 | Beyond the replication-competent HIV reservoir: transcription and translation-competent reservoirs. |
| Q36136779 | Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response |
| Q41468737 | Blockade of PD-1 or p38 MAP kinase signaling enhances senescent human CD8(+) T-cell proliferation by distinct pathways |
| Q57285037 | Bone marrow-derived CD4 T cells are depleted in SIV-infected macaques and contribute to the size of the replication competent reservoir on ART |
| Q42252882 | Boosters of a therapeutic HIV-1 vaccine induce divergent T cell responses related to regulatory mechanisms |
| Q34390492 | CD160 and PD-1 co-expression on HIV-specific CD8 T cells defines a subset with advanced dysfunction |
| Q41758430 | CD160 isoforms and regulation of CD4 and CD8 T-cell responses |
| Q34841938 | CD4 T Cells Mediate Both Positive and Negative Regulation of the Immune Response to HIV Infection: Complex Role of T Follicular Helper Cells and Regulatory T Cells in Pathogenesis |
| Q36086676 | CD4+ CD25+ regulatory T cells impair HIV-1-specific CD4 T cell responses by upregulating interleukin-10 production in monocytes |
| Q37416246 | CD8 T cell exhaustion in human visceral leishmaniasis |
| Q59357830 | CRISPR/Cas9-mediated deletion of miR-146a enhances antiviral response in HIV-1 infected cells |
| Q47608280 | CTLA-4+PD-1- Memory CD4+ T Cells Critically Contribute to Viral Persistence in Antiretroviral Therapy-Suppressed, SIV-Infected Rhesus Macaques |
| Q97883527 | Cancer and HIV-1 Infection: Patterns of Chronic Antigen Exposure |
| Q64083383 | Cat and Mouse: HIV Transcription in Latency, Immune Evasion and Cure/Remission Strategies |
| Q38098176 | Cell-Mediated Immunity in Elite Controllers Naturally Controlling HIV Viral Load. |
| Q37403487 | Cellular and molecular mechanisms of memory T-cell survival |
| Q28730828 | Characteristics and outcomes of initial virologic suppressors during analytic treatment interruption in a therapeutic HIV-1 gag vaccine trial |
| Q40581381 | Chronic HIV-1 Infection Impairs Superantigen-Induced Activation of Peripheral CD4+CXCR5+PD-1+ Cells, With Relative Preservation of Recall Antigen-Specific Responses |
| Q93032892 | Chronic Viral Infection Promotes Efficient Germinal Center B Cell Responses |
| Q34783806 | Chronic human infection with Trypanosoma cruzi drives CD4+ T cells to immune senescence |
| Q38826536 | Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy |
| Q34536782 | Clinical development of monoclonal antibody-based drugs in HIV and HCV diseases |
| Q35137038 | Coinfection with HIV-1 and HCV--a one-two punch |
| Q37247467 | Combination antiretroviral therapy with raltegravir leads to rapid immunologic reconstitution in treatment-naive patients with chronic HIV infection. |
| Q45352003 | Control of HIV infection: escape from the shadow of Blimp-1. |
| Q38420016 | Cooperative regulation of NOTCH1 protein-phosphatidylinositol 3-kinase (PI3K) signaling by NOD1, NOD2, and TLR2 receptors renders enhanced refractoriness to transforming growth factor-beta (TGF-beta)- or cytotoxic T-lymphocyte antigen 4 (CTLA-4)-med |
| Q34891171 | Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. |
| Q33805995 | Correlating cellular and molecular signatures of mucosal immunity that distinguish HIV controllers from noncontrollers |
| Q36919711 | Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease |
| Q35627631 | Cystine-knot peptides targeting cancer-relevant human cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). |
| Q46032365 | Cytomegalovirus and HIV Persistence: Pouring Gas on the Fire. |
| Q90388977 | Cytotoxic T-Lymphocyte-Associated Antigen 4 (CTLA-4)- and Programmed Death 1 (PD-1)-Mediated Regulation of Monofunctional and Dual Functional CD4+ and CD8+ T-Cell Responses in a Chronic Helminth Infection |
| Q56899966 | Cytotoxic T-lymphocyte antigen 4 blockade augments the T-cell response primed by attenuated Listeria monocytogenes resulting in more rapid clearance of virulent bacterial challenge |
| Q35793089 | Deconvolving heterogeneity in the CD8+ T-cell response to HIV. |
| Q40163118 | Decrease of CD69 levels on TCR Vα7.2+CD4+ innate-like lymphocytes is associated with impaired cytotoxic functions in chronic hepatitis B virus-infected patients. |
| Q37387280 | Decreased 4-1BB expression on HIV-specific CD4+ T cells is associated with sustained viral replication and reduced IL-2 production |
| Q38114911 | Dendritic cell dysregulation during HIV-1 infection |
| Q40042407 | Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection |
| Q64229951 | Differential Pathogen-Specific Immune Reconstitution in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Children |
| Q37644041 | Differential impact of PD-1 and/or interleukin-10 blockade on HIV-1-specific CD4 T cell and antigen-presenting cell functions |
| Q55365295 | Differentiation and Function of Follicular CD8 T Cells During Human Immunodeficiency Virus Infection. |
| Q34364695 | Diminished viral control during simian immunodeficiency virus infection is associated with aberrant PD-1hi CD4 T cell enrichment in the lymphoid follicles of the rectal mucosa. |
| Q34507539 | Distinctive features of CD4+ T cell dysfunction in chronic viral infections |
| Q21090808 | Down-regulation of CTLA-4 by HIV-1 Nef protein |
| Q38212667 | Dysfunctional adaptive immunity during parasitic infections |
| Q34186560 | EBV-specific CD8+ T cells from asymptomatic pediatric thoracic transplant patients carrying chronic high EBV loads display contrasting features: activated phenotype and exhausted function |
| Q35822484 | Effect of ipilimumab on the HIV reservoir in an HIV-infected individual with metastatic melanoma |
| Q35001377 | Effector mechanisms in HIV-1 infected elite controllers: highly active immune responses? |
| Q56994404 | Elite control of HIV infection: implications for vaccine design |
| Q36086732 | Elite controllers with low to absent effector CD8+ T cell responses maintain highly functional, broadly directed central memory responses |
| Q35987045 | Emergence of distinct multiarmed immunoregulatory antigen-presenting cells during persistent viral infection |
| Q36494531 | Enhanced sensitivity to IL-2 signaling regulates the clinical responsiveness of IL-12-primed CD8(+) T cells in a melanoma model |
| Q42207149 | Epigenetic repression of interleukin 2 expression in senescent CD4+ T cells during chronic HIV type 1 infection. |
| Q35029429 | Epithelial adhesion molecules can inhibit HIV-1-specific CD8⁺ T-cell functions |
| Q36851936 | Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals |
| Q57172787 | Evolving Paradigms in HIV Malignancies: Review of Ongoing Clinical Trials |
| Q45362051 | Exhausted or just sleeping: awakening virus-specific responses in chronic hepatitis C virus infection |
| Q34403006 | Expansion or depletion of T follicular helper cells during HIV infection: consequences for B cell responses |
| Q36684521 | Experimental Persistent Infection of BALB/c Mice with Small-Colony Variants of Burkholderia pseudomallei Leads to Concurrent Upregulation of PD-1 on T Cells and Skewed Th1 and Th17 Responses |
| Q34699537 | Expression of a broad array of negative costimulatory molecules and Blimp-1 in T cells following priming by HIV-1 pulsed dendritic cells |
| Q37620568 | Fallen angels or risen apes? A tale of the intricate complexities of imbalanced immune responses in the pathogenesis and progression of immune-mediated and viral cancers |
| Q90665758 | Fast and fierce versus slow and smooth: Heterogeneity in immune responses to Plasmodium in the controlled human malaria infection model |
| Q42597816 | Finding Balance: T cell Regulatory Receptor Expression during Aging. |
| Q40798448 | Fine-tuning of CD8(+) T-cell effector functions by targeting the 2B4-CD48 interaction. |
| Q28741958 | Frequency of circulating regulatory T cells increases during chronic HIV infection and is largely controlled by highly active antiretroviral therapy |
| Q26744626 | Functional Mechanisms of Treg in the Context of HIV Infection and the Janus Face of Immune Suppression |
| Q27488289 | Functional Restoration of HCV-Specific CD8 T Cells by PD-1 Blockade Is Defined by PD-1 Expression and Compartmentalization |
| Q35175755 | Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load |
| Q34007172 | Good cell, bad cell: flow cytometry reveals T-cell subsets important in HIV disease |
| Q93186387 | HIV Infection Is Associated With Downregulation of BTLA Expression on Mycobacterium tuberculosis-Specific CD4 T Cells in Active Tuberculosis Disease |
| Q41762711 | HIV controllers maintain a population of highly efficient Th1 effector cells in contrast to patients treated in the long term. |
| Q38114915 | HIV controllers: a genetically determined or inducible phenotype? |
| Q37921949 | HIV controllers: a multifactorial phenotype of spontaneous viral suppression |
| Q27002180 | HIV therapeutic vaccines: moving towards a functional cure |
| Q38650846 | HIV-1 Infection Is Associated with Depletion and Functional Impairment of Mycobacterium tuberculosis-Specific CD4 T Cells in Individuals with Latent Tuberculosis Infection |
| Q34416428 | HIV-1 continues to replicate and evolve in patients with natural control of HIV infection |
| Q35673465 | HIV-1 impairs in vitro priming of naïve T cells and gives rise to contact-dependent suppressor T cells |
| Q41932826 | HIV-Infected Children Have Elevated Levels of PD-1+ Memory CD4 T Cells With Low Proliferative Capacity and High Inflammatory Cytokine Effector Functions |
| Q34140484 | HIV-induced T-cell activation/exhaustion in rectal mucosa is controlled only partially by antiretroviral treatment |
| Q35399263 | HIV-mediated phosphatidylinositol 3-kinase/serine-threonine kinase activation in APCs leads to programmed death-1 ligand upregulation and suppression of HIV-specific CD8 T cells |
| Q37866624 | HIV-specific CD4 T cells and immune control of viral replication |
| Q36515071 | HIV-specific CD8⁺ T cells and HIV eradication |
| Q42432007 | HIV-specific TGF-beta-positive CD4+ T cells do not express regulatory surface markers and are regulated by CTLA-4. |
| Q35372836 | HIV-specific regulatory T cells are associated with higher CD4 cell counts in primary infection |
| Q92434361 | Hepatitis C virus-specific CD4+ T cell phenotype and function in different infection outcomes |
| Q55516430 | High Frequencies of Caspase-3 Expressing Mycobacterium tuberculosis-Specific CD4+ T Cells Are Associated With Active Tuberculosis. |
| Q37676100 | How chronic viral infections impact on antigen-specific T-cell responses |
| Q49195184 | Human Immunodeficiency Virus Type-1 Elite Controllers Maintain Low Co-Expression of Inhibitory Receptors on CD4+ T Cells. |
| Q36974683 | Human immunodeficiency virus type 1 Nef induces programmed death 1 expression through a p38 mitogen-activated protein kinase-dependent mechanism |
| Q37333793 | Human immunodeficiency virus type 1 escapes from interleukin-2-producing CD4+ T-cell responses without high-frequency fixation of mutations |
| Q38676628 | Human immunodeficiency virus type-1 induces a regulatory B cell-like phenotype in vitro. |
| Q34381597 | Human type 1 and 17 responses in latent tuberculosis are modulated by coincident filarial infection through cytotoxic T lymphocyte antigen-4 and programmed death-1. |
| Q52608541 | Hyper-Expression of PD-1 Is Associated with the Levels of Exhausted and Dysfunctional Phenotypes of Circulating CD161++TCR iVα7.2+ Mucosal-Associated Invariant T Cells in Chronic Hepatitis B Virus Infection. |
| Q37271034 | IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells |
| Q35018213 | IVIg immune reconstitution treatment alleviates the state of persistent immune activation and suppressed CD4 T cell counts in CVID. |
| Q89207371 | Immune Checkpoint Blockade Restores HIV-Specific CD4 T Cell Help for NK Cells |
| Q48556375 | Immune Checkpoint Blockade in Breast Cancer Therapy |
| Q47138765 | Immune Checkpoint Inhibitors in Melanoma and HIV Infection |
| Q28298214 | Immune Checkpoint Proteins: A New Therapeutic Paradigm for Cancer—Preclinical Background: CTLA-4 and PD-1 Blockade |
| Q56891188 | Immune Checkpoints as the Immune System Regulators and Potential Biomarkers in HIV-1 Infection |
| Q47600062 | Immune Interventions to Eliminate the HIV Reservoir |
| Q37199493 | Immune activation and collateral damage in AIDS pathogenesis. |
| Q37400623 | Immune activation driven by CTLA-4 blockade augments viral replication at mucosal sites in simian immunodeficiency virus infection. |
| Q38603237 | Immune activation in the course of HIV-1 infection: Causes, phenotypes and persistence under therapy |
| Q41921732 | Immune checkpoint blockade in infectious diseases |
| Q38020961 | Immune checkpoints in central nervous system autoimmunity. |
| Q33992829 | Immune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it? |
| Q34575451 | Immune mechanisms of HIV control |
| Q28740359 | Immune modulation through 4-1BB enhances SIV vaccine protection in non-human primates against SIVmac251 challenge |
| Q30362489 | Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure? |
| Q33907609 | Immune tolerance induction by integrating innate and adaptive immune regulators |
| Q34033051 | Immunity to HIV in Early Life |
| Q33427803 | Immunodominant HIV-1 Cd4+ T cell epitopes in chronic untreated clade C HIV-1 infection |
| Q43608840 | Immunogenic and tolerogenic signatures in human immunodeficiency virus (HIV)-infected controllers compared with progressors and a conversion strategy of virus control |
| Q59098671 | Immunology and the elusive AIDS vaccine |
| Q37444276 | Immunopathogenesis of AIDS. |
| Q34608946 | Immunopathogenesis of asymptomatic chronic HIV Infection: the calm before the storm |
| Q51898059 | Immunosuppressive mechanisms during viral infectious diseases. |
| Q36431677 | Immunotherapies: the blockade of inhibitory signals |
| Q34235198 | Impact of MHC class I diversity on immune control of immunodeficiency virus replication |
| Q53823468 | Impact of intensification with raltegravir on HIV-1-infected individuals receiving monotherapy with boosted PIs. |
| Q35925669 | Impaired NK Cell Activation and Chemotaxis toward Dendritic Cells Exposed to Complement-Opsonized HIV-1. |
| Q37114482 | Impaired function of CTLA-4 in the lungs of patients with chronic beryllium disease contributes to persistent inflammation |
| Q33402486 | In vitro priming recapitulates in vivo HIV-1 specific T cell responses, revealing rapid loss of virus reactive CD4 T cells in acute HIV-1 infection |
| Q37381314 | In vivo blockade of the programmed cell death-1 pathway using soluble recombinant PD-1-Fc enhances CD4+ and CD8+ T cell responses but has limited clinical benefit |
| Q58999342 | Increased Frequency of Antigen-Specific Polyfunctional T Cells in Tuberculosis Patients |
| Q30372415 | Increased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers. |
| Q41856139 | Induction of Multiple Immune Regulatory Pathways with Differential Impact in HCV/HIV Coinfection |
| Q34075730 | Inhibitory phenotype of HBV-specific CD4+ T-cells is characterized by high PD-1 expression but absent coregulation of multiple inhibitory molecules |
| Q38206528 | Inhibitory receptor molecules in chronic hepatitis B and C infections: novel targets for immunotherapy? |
| Q34264559 | Inhibitory receptors are expressed by Trypanosoma cruzi-specific effector T cells and in hearts of subjects with chronic Chagas disease |
| Q56901071 | Inhibitory receptors: whose side are they on? |
| Q28079717 | Innate and Adaptive Immune Regulation During Chronic Viral Infections |
| Q42130441 | Innate and Adaptive Immunity in Long-Term Non-Progression in HIV Disease |
| Q33902354 | Innate immunity defines the capacity of antiviral T cells to limit persistent infection |
| Q38114912 | Insights into B cells and HIV-specific B-cell responses in HIV-infected individuals |
| Q36593479 | Interleukin-35 Limits Anti-Tumor Immunity |
| Q47572163 | Irreversible phenotypic perturbation and functional impairment of B cells during HIV-1 infection |
| Q38687375 | Is autoimmunity the Achilles' heel of cancer immunotherapy? |
| Q40838635 | KLRG1 and PD-1 expression are increased on T-cells following tuberculosis-treatment and identify cells with different proliferative capacities in BCG-vaccinated adults |
| Q47098436 | Leptin regulates Granzyme-A, PD-1 and CTLA-4 expression in T cell to control visceral leishmaniasis in BALB/c Mice |
| Q41842825 | Ligand-independent exhaustion of killer immunoglobulin-like receptor-positive CD8+ T cells in human immunodeficiency virus type 1 infection |
| Q35164457 | Limited immunogenicity of HIV CD8+ T-cell epitopes in acute Clade C virus infection |
| Q38086432 | Long-Term Non-Progression and Broad HIV-1-Specific Proliferative T-Cell Responses |
| Q38748743 | Longitudinal analysis of the human T cell response during acute hantavirus infection. |
| Q36512579 | Longitudinal microarray analysis of cell surface antigens on peripheral blood mononuclear cells from HIV+ individuals on highly active antiretroviral therapy |
| Q42706504 | Low levels of NF-κB/p65 mark anergic CD4+ T cells and correlate with disease severity in sarcoidosis |
| Q34381879 | Lymphocyte activation gene-3 expression defines a discrete subset of HIV-specific CD8+ T cells that is associated with lower viral load |
| Q35153496 | Lymphocytic alveolitis is associated with the accumulation of functionally impaired HIV-specific T cells in the lung of antiretroviral therapy-naive subjects |
| Q50087578 | Mechanisms of CD8+ T cell-mediated suppression of HIV/SIV replication. |
| Q33828507 | Mechanisms of Virologic Control and Clinical Characteristics of HIV+ Elite/Viremic Controllers |
| Q42233499 | Minocycline attenuates HIV-1 infection and suppresses chronic immune activation in humanized NOD/LtsZ-scidIL-2Rγ(null) mice |
| Q26800047 | Molecular and cellular insights into T cell exhaustion |
| Q38091548 | Molecular signatures of T-cell inhibition in HIV-1 infection |
| Q55347049 | Multi-Donor Longitudinal Antibody Repertoire Sequencing Reveals the Existence of Public Antibody Clonotypes in HIV-1 Infection. |
| Q40052430 | Multiple Sclerosis and Subsequent Human Immunodeficiency Virus Infection: A Case with the Rare Comorbidity, Focus on Novel Treatment Issues and Review of the Literature. |
| Q36255107 | Nef promotes evasion of human immunodeficiency virus type 1-infected cells from the CTLA-4-mediated inhibition of T-cell activation |
| Q33849488 | Negative Regulation of Hepatic Inflammation by the Soluble Resistance-Related Calcium-Binding Protein via Signal Transducer and Activator of Transcription 3. |
| Q34845501 | Negative regulation of type I IFN expression by OASL1 permits chronic viral infection and CD8⁺ T-cell exhaustion. |
| Q38915896 | Novel immunological strategies for HIV-1 eradication |
| Q56900749 | Novel therapies targeting the immune system: CTLA4 blockade with tremelimumab (CP-675,206), a fully human monoclonal antibody |
| Q38161483 | On the role of co-inhibitory molecules in dendritic cell: T helper cell coculture assays aimed to detect chemical-induced contact allergy |
| Q33938039 | Opposing positive and negative regulation of T cell activity during viral persistence |
| Q42260573 | PD-1 analysis on CD28(-) CD27(-) CD4 T cells allows stimulation-independent assessment of CMV viremic episodes in transplant recipients |
| Q37469795 | PD-1 and CTLA-4 inhibitory cosignaling pathways in HIV infection and the potential for therapeutic intervention |
| Q38095246 | PD-1 coinhibitory signals: the link between pathogenesis and protection |
| Q37726682 | PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors |
| Q36750008 | PD-1 promotes immune exhaustion by inducing antiviral T cell motility paralysis |
| Q35688947 | PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid Cancer |
| Q38773102 | Paediatric HIV infection: the potential for cure |
| Q37804860 | Pathogenic Mechanisms of HIV Disease |
| Q43070781 | Persistent low-level viremia in HIV-1 elite controllers and relationship to immunologic parameters |
| Q41716501 | Phenotype alterations in regulatory T-cell subsets in primary HIV infection and identification of Tr1-like cells as the main interleukin 10-producing CD4+ T cells |
| Q37046087 | Phenotype, function, and gene expression profiles of programmed death-1(hi) CD8 T cells in healthy human adults |
| Q35071204 | Polyfunctional T cell responses in children in early stages of chronic Trypanosoma cruzi infection contrast with monofunctional responses of long-term infected adults |
| Q35162498 | Polymorphisms in the IFNγ, IL-10, and TGFβ genes may be associated with HIV-1 infection |
| Q34056881 | Polymorphisms in toll-like receptor 4 and toll-like receptor 9 influence viral load in a seroincident cohort of HIV-1-infected individuals |
| Q35883043 | Positive and negative regulation of cellular immune responses in physiologic conditions and diseases |
| Q34612545 | Preclinical evaluation of HIV-1 therapeutic ex vivo dendritic cell vaccines expressing consensus Gag antigens and conserved Gag epitopes |
| Q36666548 | Presence of suppressor HIV-specific CD8+ T cells is associated with increased PD-1 expression on effector CD8+ T cells |
| Q38267445 | Preserving HIV-specific T cell responses: does timing of antiretroviral therapy help? |
| Q60938672 | Principles of Immunotherapy: Implications for Treatment Strategies in Cancer and Infectious Diseases |
| Q39201703 | Programming T cell Killers for an HIV Cure: Teach the New Dogs New Tricks and Let the Sleeping Dogs Lie |
| Q33605792 | Proportions of circulating follicular helper T cells are reduced and correlate with memory B cells in HIV-infected children. |
| Q35070236 | Protective efficacy of individual CD8+ T cell specificities in chronic viral infection |
| Q36951735 | Public T cell receptors confer high-avidity CD4 responses to HIV controllers |
| Q90342145 | Recombinant Human Interleukin-15 and Anti-PD-L1 Combination Therapy Expands a CXCR3+PD1-/low CD8 T-Cell Subset in Simian Immunodeficiency Virus-Infected Rhesus Macaques |
| Q92214923 | Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1 |
| Q37700859 | Regulation of virus-specific CD4+ T cell function by multiple costimulatory receptors during chronic HIV infection |
| Q52715799 | Regulatory T Cells As Potential Targets for HIV Cure Research. |
| Q81355901 | Regulatory T cells in HIV infection: who's suppressing what? |
| Q37139998 | Regulatory T cells in HIV infection: who's suppressing what? |
| Q49979151 | Regulatory T cells in retroviral infections |
| Q64275677 | Remembering the forgotten child: the role of immune checkpoint inhibition in patients with human immunod eficiency virus and cancer |
| Q35140996 | Responsiveness of HIV-specific CD4 T cells to PD-1 blockade |
| Q64966359 | Restoration of HCV-Specific Immune Responses with Antiviral Therapy: A Case for DAA Treatment in Acute HCV Infection. |
| Q33714165 | Reversal of NK-cell exhaustion in advanced melanoma by Tim-3 blockade |
| Q44670813 | Reversal of functional defects in highly differentiated young and old CD8 T cells by PDL blockade |
| Q34466498 | Role of PD-1 co-inhibitory pathway in HIV infection and potential therapeutic options |
| Q24634293 | Role of PD-1 in HIV pathogenesis and as target for therapy |
| Q34612821 | Role of the Fas/FasL pathway in HIV or SIV disease |
| Q45368686 | Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection |
| Q35871953 | Selective Loss of Early Differentiated, Highly Functional PD1high CD4 T Cells with HIV Progression |
| Q36937145 | Selective expansion of a subset of exhausted CD8 T cells by alphaPD-L1 blockade |
| Q37055402 | Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication |
| Q36269639 | Silymarin suppresses basal and stimulus-induced activation, exhaustion, differentiation, and inflammatory markers in primary human immune cells |
| Q36108518 | Single-Cell Characterization of Viral Translation-Competent Reservoirs in HIV-Infected Individuals |
| Q35587218 | Site-specific differences in T cell frequencies and phenotypes in the blood and gut of HIV-uninfected and ART-treated HIV+ adults |
| Q92404807 | Striking a Balance-Cellular and Molecular Drivers of Memory T Cell Development and Responses to Chronic Stimulation |
| Q38491191 | Success and failure of the cellular immune response against HIV-1. |
| Q27487939 | Synergistic Reversal of Intrahepatic HCV-Specific CD8 T Cell Exhaustion by Combined PD-1/CTLA-4 Blockade |
| Q35842352 | Systemic inhibition of myeloid dendritic cells by circulating HLA class I molecules in HIV-1 infection |
| Q29620463 | T cell exhaustion |
| Q35582265 | T cell exhaustion during persistent viral infections |
| Q27022690 | T cell replicative senescence in human aging |
| Q39026157 | T-Cell Receptor (TCR) Clonotype-Specific Differences in Inhibitory Activity of HIV-1 Cytotoxic T-Cell Clones Is Not Mediated by TCR Alone. |
| Q35666026 | T-Cell Subsets Predict Mortality in Malnourished Zambian Adults Initiating Antiretroviral Therapy |
| Q92291598 | T-cell exhaustion in HIV infection |
| Q37139996 | T-cell exhaustion in HIV infection. |
| Q28083810 | T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance |
| Q34102010 | T-cell exhaustion: characteristics, causes and conversion |
| Q36513955 | TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection |
| Q33519047 | TGF-beta and IL-10 production by HIV-specific CD8+ T cells is regulated by CTLA-4 signaling on CD4+ T cells |
| Q56897131 | TIM-3, a Possible Target for Immunotherapy in Cancer and Chronic Viral Infections |
| Q26745923 | Targeting the latent reservoir to achieve functional HIV cure |
| Q50131761 | The Biology of Monocytes and Dendritic Cells: Contribution to HIV Pathogenesis |
| Q35728956 | The CTLA-4 and PD-1/PD-L1 inhibitory pathways independently regulate host resistance to Plasmodium-induced acute immune pathology |
| Q47975503 | The Foxo and the hound: chasing the in vivo regulation of T cell populations during infection |
| Q97883485 | The Role of Immunomodulatory Receptors in the Pathogenesis of HIV Infection: A Therapeutic Opportunity for HIV Cure? |
| Q59806975 | The Roles of Coinhibitory Receptors in Pathogenesis of Human Retroviral Infections |
| Q45324456 | The Significance of Type-I Interferons in the Pathogenesis and Therapy of Human Immunodeficiency Virus 1 Infection |
| Q98504318 | The T cell differentiation landscape is shaped by tumour mutations in lung cancer |
| Q40481911 | The Vast Universe of T Cell Diversity: Subsets of Memory Cells and Their Differentiation. |
| Q37287296 | The diversity of costimulatory and inhibitory receptor pathways and the regulation of antiviral T cell responses. |
| Q92476068 | The forces driving clonal expansion of the HIV-1 latent reservoir |
| Q37027166 | The growth and potential of human antiviral monoclonal antibody therapeutics. |
| Q27002959 | The immunological synapse: the gateway to the HIV reservoir |
| Q38037339 | The impact of differential antiviral immunity in children and adults |
| Q52430553 | The latest evidence for possible HIV-1 curative strategies. |
| Q37451618 | The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer. |
| Q36380567 | The role of IL-10 in regulating immunity to persistent viral infections |
| Q34629141 | The third signal cytokine IL-12 rescues the anti-viral function of exhausted HBV-specific CD8 T cells |
| Q36155524 | Therapeutic blockade of transforming growth factor beta fails to promote clearance of a persistent viral infection |
| Q36010933 | Thirty Years with HIV Infection-Nonprogression Is Still Puzzling: Lessons to Be Learned from Controllers and Long-Term Nonprogressors |
| Q36384423 | Tim-3-expressing CD4+ and CD8+ T cells in human tuberculosis (TB) exhibit polarized effector memory phenotypes and stronger anti-TB effector functions |
| Q33614649 | Tissue-specific differences in PD-1 and PD-L1 expression during chronic viral infection: implications for CD8 T-cell exhaustion |
| Q26797214 | Tryptophan Catabolism in Chronic Viral Infections: Handling Uninvited Guests |
| Q36065998 | Tuberculosis Therapy Modifies the Cytokine Profile, Maturation State, and Expression of Inhibitory Molecules on Mycobacterium tuberculosis-Specific CD4+ T-Cells |
| Q37426844 | Understanding B cell activation: from single molecule tracking, through Tolls, to stalking memory in malaria |
| Q34525050 | Unique human immune signature of Ebola virus disease in Guinea |
| Q35839496 | Update on hepatitis C virus-specific immunity |
| Q38223279 | Viral (hepatitis C virus, hepatitis B virus, HIV) persistence and immune homeostasis |
| Q36434375 | p38 Mitogen-activated protein kinase/signal transducer and activator of transcription-3 pathway signaling regulates expression of inhibitory molecules in T cells activated by HIV-1-exposed dendritic cells |
| Q33475710 | siRNA knockdown of PD-L1 and PD-L2 in monocyte-derived dendritic cells only modestly improves proliferative responses to Gag by CD8(+) T cells from HIV-1-infected individuals |
Search more.